Science and Practice for Heated Tobacco Products, 1st ed. 2021 Japan as a Test Bed for Novel Tobacco Products

The main focus of this book is providing evidence on and interpreting the risks associated with heated tobacco products (HTPs) in terms of their health effects and social effects; in addition, the author introduces a harm reduction theory related to HTPs and electronic cigarettes. The book also addresses the history of these products, their marketing strategies, and policy implications. These products are new and the accompanying health risks have yet to be determined. However, since Japan accounts for more than 80% of the world?s market for IQOS, the most popular heated tobacco product, researchers around the globe will be very interested in the outcomes. 

Written by a leading researcher in the field of tobacco control, Science and Practice for Heated Tobacco Products offers a valuable, unique resource for researchers in the fields of epidemiology, public health, social sciences, addiction, and tobacco research. Since tobacco is associated with a host of diseases including cancers, cardiovascular diseases, diabetes mellitus, and respiratory illnesses, researchers and healthcare workers whose work involves these diseases will find this book both thought provoking and insightful.

Chapter 1: Introduction

Foreword

Section 1: What’s the Big Problem with New Tobacco Products?

Section 2: What We Must Understand about New Tobacco Products

Section 3: The Very Image of HTPs is Dubious

Chapter 2: Tobacco Products in Japan including a History of Heated Tobacco Products

Section 1: New Tobacco Products are Taking Japan by Storm

Section 2: No Innovation – They’ve been around a Long Time

Chapter 3: The JASTIS project: product use status in Japan

Section 1: New Tobacco Products got their Start from “Ame-Talk”: Google Trends Study

Section 2: New Tobacco Product use in Japan: the JASTIS study

Section 3:  Why Are New Tobacco Products So Popular?

Section 4:  Japan - the Global Test Site for IQOS

Chapter 4: Marketing Strategy for Tobacco Products in Japan

Section 1:  The Japanese Love a New Gadget

Section 2: The Japanese Public:  Manipulated with Imagery and Led to Misunderstanding

Column: There is no “Light” Tobacco

Section 3: The Risks of Tobacco the Media won’t Report, and Why Not

Section 4: The Tobacco Companies’ Outrageous Insult to Smokers

Chapter 5: Substances in Novel Tobacco Products

Section 1: The Harmful Substances in Tobacco Smoke: basic information from public health perspective

Column:  The Trap of the “Mechanism”

Section 2: The Harmful Substances in HTP Aerosol

Column:  “Heat Not Burn”?  Not Really

Section 3: The Many Unresearched Substances in HTP Aerosol

Column:  IQOS Compatible Devices

Section 4: The Harmful Substances in e-Cigarette Aerosol

Chapter 6: Health effect

Section 1: Risk of Cancer

Section 3: Increasing Nicotine Dependence

Section 4: The Pluses and Minuses of Passive Smoke from New Tobacco Products -- Children and Family Members are at Risk

Section 5:  EVALI:  e-Cigarette or Vaping Product use Associated Lung Injury

Chapter 7: Social Effect

Section 1: Are New Tobacco Products Cigarettes or Not?

Section 2: New Tobacco Products are Changing all the Rules

Section 3: With the Introduction of New Tobacco Products, the Difficulty Level of Tobacco Control has Increased Sharply

Section 4: New Tobacco Products have brought New Problems to Society

Section 5: How our Attitudes have been Warped by the Tobacco Industry

Section 6: Fanning the Flames of Confrontation to Keep Tobacco Alive

Chapter 8: Interpretation of Risks of Novel Tobacco Products, including Harm Reduction Theory

Section 1: How can we Interpret the Risks of New Tobacco Products

Section 2: Will We Ever Really Know the Health Risks of New Tobacco Products?

Section 4: What is Optimal for Comparing with New Tobacco Products?

Column:  The Unknown Risks of New Tobacco Products

Section 1: Cessation in the Era of New Tobacco Products

For smokers

For Medical Doctors

Chapter 10: Policy implication including interference in tobacco control measures with new tobacco products

Section 1: For the People who Make the Rules for our Society (Legislators and Bureaucrats)

Section 2: View of The World Health Organization

Section 3: View from IARC Classifications: “Tobacco Smoke” as a Carcinogen

Section 4: Can We Trust the Tobacco Companies?：Interference in Tobacco Control Measures with New Tobacco Products

Column:  Understanding JT is the Key to Understanding Japan’s Tobacco Problem

Chapter 11: Conclusions

Implication for future work

The World isn’t Logical nor Right

A Matter of Degree

So, in the end, what should we do?

Takahiro Tabuchi, MD, PhD
Department of Cancer Epidemiology,
Cancer Control Center,
Osaka International Cancer Institute

Provides facts and first-hand analyses concerning the health and social effects of novel tobacco products in Japan

Offers a valuable, unique resource for researchers in the fields of epidemiology, public health, social sciences, addiction, and tobacco research, since Japan accounts for more than 80% of worldwide market for IQOS, the most popular heated tobacco product

Provides deep insight for those who treat patients with cancers, cardiovascular diseases, diabetes mellitus, and respiratory illnesses